LivaNova PLC Share-based Payment Arrangement, Expensed and Capitalized, Amount
LivaNova PLC (LIVN) reported Share-based Payment Arrangement, Expensed and Capitalized, Amount of $2.10 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 · last filed 2025-08-06
- LivaNova PLC share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2025-06-30 was $2.10M, a 16.00% decline year-over-year.
- LivaNova PLC share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2025-03-31 was $100.00K, a 0.00% change year-over-year.
- LivaNova PLC share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2024-12-31 was $8.90M.
- LivaNova PLC share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2024-09-30 was $3.40M, a 24.44% decline year-over-year.
| Period end | Share-based Payment Arrangement, Expensed and Capitalized, Amount 3 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 6 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 9 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 12 month |
|---|---|---|---|---|
| 2025-06-30 | $2.10M 10-Q · filed 2025-08-06 | $2.30M 10-Q · filed 2025-08-06 | $11.10M derived: sum of 3 quarters · filed 2025-08-06 | $14.50M derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-07 | $9.00M derived: sum of 2 quarters · filed 2025-05-07 | $12.40M derived: sum of 3 quarters · filed 2025-05-07 | $14.90M derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-12-31 | $8.90M 10-K · filed 2025-02-25 | $12.30M derived: sum of 2 quarters · filed 2025-02-25 | $14.80M derived: sum of 3 quarters · filed 2025-02-25 | $14.90M derived: sum of 4 quarters · filed 2025-02-25 |
| 2024-09-30 | $3.40M 10-Q · filed 2024-10-31 | $5.90M derived: sum of 2 quarters · filed 2024-10-31 | $6.00M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $2.50M 10-Q · filed 2024-08-01 | $2.60M 10-Q · filed 2024-08-01 | ||
| 2024-03-31 | $100.00K 10-Q · filed 2024-05-03 | |||
| 2023-09-30 | $4.50M 10-Q · filed 2023-11-01 | $6.90M derived: sum of 2 quarters · filed 2023-11-01 | $6.90M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $2.40M 10-Q · filed 2023-07-26 | $2.50M 10-Q · filed 2023-07-26 | ||
| 2023-03-31 | $100.00K 10-Q · filed 2023-05-03 | |||
| 2022-09-30 | $3.40M 10-Q · filed 2022-11-02 | $6.30M derived: sum of 2 quarters · filed 2022-11-02 | $6.50M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $3.00M 10-Q · filed 2022-08-03 | ||
| 2022-03-31 | $100.00K 10-Q · filed 2022-05-04 | |||
| 2021-09-30 | $3.90M 10-Q · filed 2021-11-03 | $7.20M derived: sum of 2 quarters · filed 2021-11-03 | $7.30M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $3.30M 10-Q · filed 2021-07-28 | $3.40M 10-Q · filed 2021-07-28 | ||
| 2021-03-31 | $100.00K 10-Q · filed 2021-04-28 | |||
| 2020-09-30 | $3.30M 10-Q · filed 2020-10-29 | $6.10M derived: sum of 2 quarters · filed 2020-10-29 | $6.60M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $2.80M 10-Q · filed 2020-07-29 | $3.20M 10-Q · filed 2020-07-29 | ||
| 2020-03-31 | $400.00K 10-Q · filed 2020-04-30 | |||
| 2019-09-30 | $3.60M 10-Q · filed 2019-10-30 | $6.70M derived: sum of 2 quarters · filed 2019-10-30 | $6.80M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $3.10M 10-Q · filed 2019-07-31 | $3.20M 10-Q · filed 2019-07-31 | ||
| 2019-03-31 | $100.00K 10-Q · filed 2019-05-01 | |||
| 2018-09-30 | $3.40M 10-Q · filed 2018-11-01 | $6.80M derived: sum of 2 quarters · filed 2018-11-01 | $7.30M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $3.40M 10-Q · filed 2018-08-02 | $3.90M 10-Q · filed 2018-08-02 | ||
| 2018-03-31 | $500.00K 10-Q · filed 2018-05-03 | |||
| 2017-09-30 | $2.00M 10-Q · filed 2017-11-02 | $3.20M derived: sum of 2 quarters · filed 2017-11-02 | $3.20M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $1.20M 10-Q · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |